Paper highlights best practices for omega-3 clinical trials with cardiovascular outcomes

A paper published last week in Prostaglandins, Leukotrienes and Essential Fatty Acids sheds new light on recent neutral studies questioning the benefits of omega-3s for heart health. The paper, ‘Conducting Omega-3 Clinical Trials with Cardiovascular Outcomes: Proceedings of a Workshop Held at ISSFAL 2014,’ identifies experimental design issues in recent studies that have not demonstrated significant effects of EPA and DHA omega-3s on cardiovascular disease outcomes. —> Read More